Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature
Open Access
- 20 June 2018
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 74 (10) , 1235-1248
Abstract
Pharmacovigilance education is essential since adverse drug reactions (ADRs) are a serious health problem and contribute to unnecessary patient burden and hospital admissions. Healthcare professionals have little awareness of pharmacovigilance and ADR reporting, and only few educational interventions had durable effects on this awareness. Our future healthcare providers should therefore acquire an adequate set of pharmacovigilance competencies to rationally prescribe, distribute, and monitor drugs. We investigated the pharmacovigilance and ADR-reporting competencies of healthcare students to identify educational interventions that are effective in promoting pharmacovigilance.Keywords
Funding Information
- Vanderbilt University Medical Center
This publication has 62 references indexed in Scilit:
- Cost of illness of patient-reported adverse drug events: a population-based cross-sectional surveyBMJ Open, 2013
- Pharmacy Students’ Attitudes Toward Reporting Serious Adverse Drug EventsAmerican Journal of Pharmaceutical Education, 2012
- Pharmacy Students’ Knowledge and Perceptions About Pharmacovigilance in Malaysian Public UniversitiesAmerican Journal of Pharmaceutical Education, 2011
- Determinants of Under-Reporting of Adverse Drug ReactionsDrug Safety, 2009
- Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological courseBritish Journal of Clinical Pharmacology, 2007
- A systematic review of faculty development initiatives designed to improve teaching effectiveness in medical education: BEME Guide No. 8Medical Teacher, 2006
- Under-Reporting of Adverse Drug ReactionsDrug Safety, 2006
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ, 2004
- Under‐reporting of serious adverse drug reactions in SwedenPharmacoepidemiology and Drug Safety, 2004
- The Dawn of PharmacovigilanceInternational Journal of Pharmaceutical Medicine, 2003